88 - Dr Lisa Rister - Part 2 (GLP-1 Drugs: Risks, Side Effects, and What Chiropractors Need to Know)

In Part 2 of our interview with Dr Lisa Rister, hosts Paul Andrews and Dr. Mark Davini continue their conversation with Dr. Rister about GLP-1 medications and the evolving obesity-medicine landscape. The discussion covers how these drugs work, potential side effects like dopamine suppression and mood changes, and emerging agents. Dr. Rister outlines practical clinical concerns for chiropractors and patients: the importance of individualized care, nutrition and lifestyle management, monitoring body composition (lean muscle vs. fat loss), micronutrient deficiencies, osteoporosis risk, and safe titration to reduce toxin release and side effects. The episode also addresses the challenges of easy online access to prescriptions, medico-legal implications, and how to collaborate with prescribers. Key takeaways include counseling patients before starting medication, running targeted tests (e.g., fasting insulin, micronutrient panels), tailored supplement strategies, and providing ongoing support for titration and maintenance. For resources mentioned in the episode, listeners can visit spinalcarechiropractic.com (https://spinalcarechiropractic.com/ba...) or email insurance@spinalcarechiropractic.com.